Clinical Trials Logo

Papular-pustular Rosacea clinical trials

View clinical trials related to Papular-pustular Rosacea.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT00882531 Completed - Clinical trials for Papular-pustular Rosacea

Isotretinoin in Papular-Pustular Rosacea

ISOROS
Start date: February 2007
Phase: Phase 3
Study type: Interventional

A national, multicentre, prospective, randomised, double-blind, phase III study in 2 parallel groups of isotretinoin versus placebo in patients presenting papular-pustular rosacea resistant to standard therapy. A non-balanced group (2 isotretinoin /1 placebo) design was selected since, given the nature of the study disease, fewer patients will receive the placebo than active isotretinoin. Treatment duration for each patient : 4 months, with monthly evaluation Follow-up at 2 months and 4 months for patients responsive after 4 months of treatment.